Literature DB >> 20841568

ABL tyrosine kinases: evolution of function, regulation, and specificity.

John Colicelli1.   

Abstract

ABL-family proteins comprise one of the best conserved branches of the tyrosine kinases. Each ABL protein contains an SH3-SH2-TK (Src homology 3-Src homology 2-tyrosine kinase) domain cassette, which confers autoregulated kinase activity and is common among nonreceptor tyrosine kinases. This cassette is coupled to an actin-binding and -bundling domain, which makes ABL proteins capable of connecting phosphoregulation with actin-filament reorganization. Two vertebrate paralogs, ABL1 and ABL2, have evolved to perform specialized functions. ABL1 includes nuclear localization signals and a DNA binding domain through which it mediates DNA damage-repair functions, whereas ABL2 has additional binding capacity for actin and for microtubules to enhance its cytoskeletal remodeling functions. Several types of posttranslational modifications control ABL catalytic activity, subcellular localization, and stability, with consequences for both cytoplasmic and nuclear ABL functions. Binding partners provide additional regulation of ABL catalytic activity, substrate specificity, and downstream signaling. Information on ABL regulatory mechanisms is being mined to provide new therapeutic strategies against hematopoietic malignancies caused by BCR-ABL1 and related leukemogenic proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20841568      PMCID: PMC2954126          DOI: 10.1126/scisignal.3139re6

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  247 in total

1.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

2.  Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.

Authors:  Charles Reichman; Kamalendra Singh; Yan Liu; Sukhwinder Singh; Hong Li; J Eduardo Fajardo; Andras Fiser; Raymond B Birge
Journal:  Oncogene       Date:  2005-12-08       Impact factor: 9.867

3.  A modular design for the clathrin- and actin-mediated endocytosis machinery.

Authors:  Marko Kaksonen; Christopher P Toret; David G Drubin
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

4.  Allosteric inhibitors of Bcr-abl-dependent cell proliferation.

Authors:  Francisco J Adrián; Qiang Ding; Taebo Sim; Anastasia Velentza; Christine Sloan; Yi Liu; Guobao Zhang; Wooyoung Hur; Sheng Ding; Paul Manley; Jürgen Mestan; Doriano Fabbro; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2006-01-15       Impact factor: 15.040

5.  Abelson, enabled, and p120 catenin exert distinct effects on dendritic morphogenesis in Drosophila.

Authors:  Wenjun Li; Yan Li; Fen-Biao Gao
Journal:  Dev Dyn       Date:  2005-11       Impact factor: 3.780

6.  Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.

Authors:  Masahiro Maruoka; Jun Suzuki; Shigehisa Kawata; Kayo Yoshida; Noriko Hirao; Seiichi Sato; Stephen P Goff; Tatsuo Takeya; Katsuko Tani; Tomoyuki Shishido
Journal:  FEBS Lett       Date:  2005-06-06       Impact factor: 4.124

7.  The microtubule plus end tracking protein Orbit/MAST/CLASP acts downstream of the tyrosine kinase Abl in mediating axon guidance.

Authors:  Haeryun Lee; Ulrike Engel; Jannette Rusch; Simone Scherrer; Katherine Sheard; David Van Vactor
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

8.  Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Markus Seeliger; Jason M Davies; William I Weis; Giulio Superti-Furga; John Kuriyan
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

9.  Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.

Authors:  Etienne Tokonzaba; Daniel G S Capelluto; Tatiana G Kutateladze; Michael Overduin
Journal:  Chem Biol Drug Des       Date:  2006-03       Impact factor: 2.817

10.  Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain.

Authors:  Tingjun Hou; Ken Chen; William A McLaughlin; Benzhuo Lu; Wei Wang
Journal:  PLoS Comput Biol       Date:  2006-01-27       Impact factor: 4.475

View more
  138 in total

1.  Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni.

Authors:  Svenja Beckmann; Steffen Hahnel; Katia Cailliau; Mathieu Vanderstraete; Edith Browaeys; Colette Dissous; Christoph G Grevelding
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

2.  Proteome-wide detection of Abl1 SH3-binding peptides by integrating computational prediction and peptide microarray.

Authors:  Zheng Xu; Tingjun Hou; Nan Li; Yang Xu; Wei Wang
Journal:  Mol Cell Proteomics       Date:  2011-10-24       Impact factor: 5.911

3.  The c-Abl expression in uterine epithelium during the mouse estrus cycle.

Authors:  A Yaba Ucar; U A Kayisli; N Demir
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

4.  Angiotensin-II and MARCKS: a hydrogen peroxide- and RAC1-dependent signaling pathway in vascular endothelium.

Authors:  Hermann Kalwa; Juliano L Sartoretto; Simone M Sartoretto; Thomas Michel
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 5.  Regulation of transcription factor activity by interconnected post-translational modifications.

Authors:  Theresa M Filtz; Walter K Vogel; Mark Leid
Journal:  Trends Pharmacol Sci       Date:  2013-12-30       Impact factor: 14.819

6.  Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap.

Authors:  Carles Corbi-Verge; Fabrizio Marinelli; Ana Zafra-Ruano; Javier Ruiz-Sanz; Irene Luque; José D Faraldo-Gómez
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

7.  Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.

Authors:  R Scott Stephens; Laura E Servinsky; Otgonchimeg Rentsendorj; Todd M Kolb; Alexander Pfeifer; David B Pearse
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-08       Impact factor: 4.249

8.  Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.

Authors:  E Letsiou; A N Rizzo; S Sammani; P Naureckas; J R Jacobson; J G N Garcia; S M Dudek
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-05       Impact factor: 5.464

9.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

10.  Fluorescence lifetime imaging of biosensor peptide phosphorylation in single live cells.

Authors:  Nur P Damayanti; Laurie L Parker; Joseph M K Irudayaraj
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-28       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.